{
  "context": {
    "cell_type": "malignant glioblastoma cell",
    "disease": "glioblastoma",
    "tissue": "brain"
  },
  "input_genes": [
    "FAM111B",
    "MYBL2",
    "EXO1",
    "ZNF367",
    "BRIP1",
    "CLSPN",
    "CHAF1A",
    "DTL",
    "PCLAF",
    "CHEK1",
    "CDC45",
    "FANCA",
    "MCM6",
    "RRM2",
    "MCM10",
    "ASF1B",
    "CENPU",
    "FANCD2",
    "POLA2",
    "MIR924HG",
    "CCNE2",
    "WDR76",
    "ESCO2",
    "FBLN7",
    "CENPK",
    "NXPH2",
    "MELK",
    "CHAF1B",
    "GRM8",
    "HELLS",
    "POLE2",
    "E2F1",
    "E2F7",
    "DHFR",
    "ABHD3",
    "CDCA7",
    "ASPN",
    "FANCI",
    "RAD18",
    "XRCC2",
    "AC008543.1",
    "GINS1",
    "AL034348.1",
    "BRCA1",
    "BRCA2",
    "SPC24",
    "KIF15",
    "AC011447.3",
    "VRK1",
    "WDHD1",
    "KIF24",
    "XYLB",
    "SKA3",
    "RAB39A",
    "LRRC63",
    "RAD54L",
    "DIAPH3",
    "CGAS",
    "CENPP",
    "SPC25",
    "CENPI",
    "PRIM2",
    "POLQ",
    "KBTBD12",
    "RAD51AP1",
    "AMPH",
    "LIG1",
    "AC007681.1",
    "MCM5",
    "AC130324.2",
    "TNFAIP8",
    "AURKB",
    "DDX11-AS1",
    "SIMC1",
    "MMS22L",
    "MCM4",
    "ATAD2",
    "FANCB",
    "DNA2",
    "AC006115.2",
    "TRPC3",
    "PLD5",
    "PLK4",
    "LIMK2",
    "ESPL1",
    "TP73",
    "ARNTL2",
    "ZNF90",
    "MBNL3",
    "AC004943.2",
    "KIAA0319",
    "COL9A1",
    "MYBL1",
    "NEIL3",
    "WDR62",
    "SDK1",
    "LAMA1",
    "CLN6",
    "PER3",
    "PCNA",
    "CCDC138",
    "ECM2",
    "CAMK4",
    "EFNA5",
    "CD83",
    "REXO5",
    "DDB2",
    "MCM8",
    "KIFC1",
    "CEP152",
    "IQGAP3",
    "AC104073.4",
    "DAPK2",
    "KNTC1",
    "ZGRF1",
    "RFC2",
    "MND1",
    "UHRF1",
    "MBOAT1",
    "SFMBT1",
    "RFC3",
    "CKAP2L",
    "POLA1",
    "KCTD16",
    "ARHGAP11B",
    "BICC1",
    "SVEP1",
    "AP002495.1",
    "FAM189A1",
    "SYK",
    "ORC6",
    "GHR",
    "FOXM1",
    "HMGN2",
    "ZNF730",
    "GLYATL2",
    "ARHGAP19",
    "HMGB2",
    "HESX1",
    "AC009630.1",
    "STAC",
    "PBK",
    "TCF19",
    "MASTL"
  ],
  "programs": [
    {
      "program_name": "DNA Replication Licensing & Fork Progression",
      "description": "Includes MCM family (MCM2,4,5,6,10), CDC45, GINS1, WDHD1, ORC6, RFC2/3, POLE2, POLA1/2, PCNA, CLSPN, CHAF1A/B, ASF1B. These genes together constitute key components for origin licensing, replisome assembly, and elongation machinery. Aberrant activity and overexpression drive rapid DNA replication and replicative stress characteristic of glioblastoma.",
      "atomic_biological_processes": [
        {
          "name": "Origin licensing (MCM loading)",
          "citation": [
            {
              "url": "https://pmc.ncbi.nlm.nih.gov/3115219/",
              "source_id": "11",
              "notes": "Describes role of MCMs in origin licensing and cancer progression"
            }
          ],
          "genes": [
            "MCM2",
            "MCM4",
            "MCM5",
            "MCM6",
            "MCM10",
            "ORC6"
          ]
        },
        {
          "name": "Replisome assembly (CMG complex, Fork progression)",
          "citation": [
            {
              "url": "https://pmc.ncbi.nlm.nih.gov/5479659/",
              "source_id": "123",
              "notes": "Explains CMG helicase complex function"
            }
          ],
          "genes": [
            "CDC45",
            "GINS1",
            "MCM2",
            "MCM4",
            "MCM5",
            "MCM6",
            "MCM10"
          ]
        },
        {
          "name": "Clamp loading and elongation",
          "citation": [
            {
              "url": "https://pmc.ncbi.nlm.nih.gov/1866948/",
              "source_id": "141",
              "notes": "RFC ensures PCNA loading for replication processivity"
            }
          ],
          "genes": [
            "RFC2",
            "RFC3",
            "PCNA"
          ]
        }
      ],
      "atomic_cellular_components": [
        {
          "name": "Replication fork",
          "citation": [
            {
              "url": "https://pmc.ncbi.nlm.nih.gov/147/",
              "source_id": "147",
              "notes": "Describes WDHD1's function in fork stability"
            }
          ],
          "genes": [
            "WDHD1",
            "MCM6",
            "CDC45",
            "GINS1",
            "PCNA"
          ]
        }
      ],
      "predicted_cellular_impact": [
        "Permissive replication origin licensing and increased fork firing enable rapid proliferation",
        "High replicative stress promoting genome instability",
        "Targets for synthetic lethality in combination therapies"
      ],
      "evidence_summary": "MCMs, GINS1, CDC45, ORC6, PCNA, RFCs, WDHD1 are all overexpressed in glioblastoma, supporting aggressive replication. Elevated expression correlates with poor prognosis, guides CDK and checkpoint targeting strategies.",
      "significance_score": 0.95,
      "citations": [
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/3115219/",
          "source_id": "11",
          "notes": "MCMs role in cancer"
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/5479659/",
          "source_id": "123",
          "notes": "CMG complex"
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/147/",
          "source_id": "147",
          "notes": "WDHD1 in fork stability"
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/1866948/",
          "source_id": "141",
          "notes": "RFCs and clamp loading"
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/130/",
          "source_id": "130",
          "notes": "ORC6 in glioma"
        }
      ],
      "supporting_genes": [
        "MCM2",
        "MCM4",
        "MCM5",
        "MCM6",
        "MCM10",
        "CDC45",
        "GINS1",
        "WDHD1",
        "ORC6",
        "RFC2",
        "RFC3",
        "PCNA",
        "ASF1B",
        "CHAF1A",
        "CHAF1B",
        "CLSPN",
        "POLE2",
        "POLA1",
        "POLA2"
      ],
      "required_genes_not_in_input": {
        "genes": [
          "MCM3",
          "MCM7"
        ],
        "citations": [
          {
            "url": "https://pmc.ncbi.nlm.nih.gov/3115219/",
            "source_id": "11",
            "notes": "MCM2-7 hexamer is required for full helicase activity"
          }
        ]
      }
    },
    {
      "program_name": "Cell Cycle Regulation & Checkpoint Control",
      "description": "Genes such as E2F1, E2F7, CCNE2, FOXM1, CHEK1, CLSPN, CDC45 regulate G1/S transition, S phase progression, and checkpoint enforcement. Glioblastoma displays hyperactivation and dysregulation, permitting uncontrolled division and resistance to genotoxic therapy.",
      "atomic_biological_processes": [
        {
          "name": "G1/S phase transition",
          "citation": [
            {
              "url": "https://pmc.ncbi.nlm.nih.gov/163/",
              "source_id": "163",
              "notes": "E2F family function in cell cycle and cancer"
            }
          ],
          "genes": [
            "CCNE2",
            "E2F1"
          ]
        },
        {
          "name": "Checkpoint activation (ATR/CHK1 pathway)",
          "citation": [
            {
              "url": "https://pmc.ncbi.nlm.nih.gov/109/",
              "source_id": "109",
              "notes": "Claspin-CHK1 activation in replication stress"
            }
          ],
          "genes": [
            "CLSPN",
            "CHEK1"
          ]
        }
      ],
      "atomic_cellular_components": [
        {
          "name": "Centrosome and spindle assembly",
          "citation": [
            {
              "url": "https://pmc.ncbi.nlm.nih.gov/114/",
              "source_id": "114",
              "notes": "WDR62 spindle pole protein in mitosis"
            }
          ],
          "genes": [
            "WDR62",
            "SKA3",
            "KIF15",
            "KIF24"
          ]
        }
      ],
      "predicted_cellular_impact": [
        "Accelerated S phase entry and division",
        "Checkpoint evasion promotes survival and chromosomal instability",
        "Potential for synthetic lethality via checkpoint inhibition"
      ],
      "evidence_summary": "Cell cycle regulators are frequently overexpressed and mutated in glioblastoma, driving unchecked proliferation and therapy resistance.",
      "significance_score": 0.87,
      "citations": [
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/163/",
          "source_id": "163",
          "notes": "E2F family in cancer"
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/42/",
          "source_id": "42",
          "notes": "FOXM1 promotes proliferation"
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/109/",
          "source_id": "109",
          "notes": "CLSPN in checkpoint"
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/110/",
          "source_id": "110",
          "notes": "CHK1 as therapy target"
        }
      ],
      "supporting_genes": [
        "E2F1",
        "E2F7",
        "CCNE2",
        "FOXM1",
        "CHEK1",
        "CLSPN",
        "CDC45",
        "CDC45",
        "CDC45",
        "WDR62",
        "SKA3",
        "KIF15",
        "KIF24"
      ],
      "required_genes_not_in_input": {
        "genes": [
          "CDK1",
          "CDK2",
          "CCNB1",
          "CCND1"
        ],
        "citations": [
          {
            "url": "https://pmc.ncbi.nlm.nih.gov/162/",
            "source_id": "162",
            "notes": "Core cell cycle kinases"
          }
        ]
      }
    },
    {
      "program_name": "DNA Damage Response & Repair (HR, FA, TLS)",
      "description": "Fanconi anemia pathway (FANCA, FANCB, FANCI, FANCD2), Homologous recombination (BRCA1/2, RAD51, RAD18, XRCC2, RAD54L, BRIP1), and translesion synthesis (RAD18, POLQ, DNA2, LIG1) genes ensure DNA repair under stress. High expression supports adaptation to genotoxic stress in glioblastoma.",
      "atomic_biological_processes": [
        {
          "name": "Interstrand crosslink repair (Fanconi anemia pathway)",
          "citation": [
            {
              "url": "https://pmc.ncbi.nlm.nih.gov/75/",
              "source_id": "75",
              "notes": "FANCD2-FANCI complex in FA repair"
            }
          ],
          "genes": [
            "FANCA",
            "FANCB",
            "FANCI",
            "FANCD2"
          ]
        },
        {
          "name": "Homologous recombination (HR)",
          "citation": [
            {
              "url": "https://pmc.ncbi.nlm.nih.gov/82/",
              "source_id": "82",
              "notes": "RAD51 recombinase in HR"
            }
          ],
          "genes": [
            "RAD51AP1",
            "RAD51",
            "BRCA1",
            "BRCA2",
            "RAD54L",
            "XRCC2"
          ]
        },
        {
          "name": "Translesion synthesis (TLS) at replication forks",
          "citation": [
            {
              "url": "https://pmc.ncbi.nlm.nih.gov/91/",
              "source_id": "91",
              "notes": "CHAF1A promotes RAD18 recruitment for TLS"
            }
          ],
          "genes": [
            "RAD18",
            "POLQ",
            "DNA2",
            "LIG1"
          ]
        }
      ],
      "atomic_cellular_components": [
        {
          "name": "DNA repair foci (chromatin-bound repair complexes)",
          "citation": [
            {
              "url": "https://pmc.ncbi.nlm.nih.gov/76/",
              "source_id": "76",
              "notes": "FANCD2, BRCA2 at replication foci"
            }
          ],
          "genes": [
            "FANCD2",
            "BRCA2",
            "RAD51"
          ]
        }
      ],
      "predicted_cellular_impact": [
        "Enhanced DNA repair capacity supports tumor survival under replicative/genotoxic stress",
        "Facilitates resistance to radiation and chemotherapy",
        "Potential to target as vulnerabilities in therapy"
      ],
      "evidence_summary": "Fanconi pathway, HR, and TLS genes frequently upregulated in glioblastoma, supporting adaptation to replication stress and DNA damage.",
      "significance_score": 0.88,
      "citations": [
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/75/",
          "source_id": "75",
          "notes": "FA pathway, FANCD2-FANCI"
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/82/",
          "source_id": "82",
          "notes": "RAD51 in HR"
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/91/",
          "source_id": "91",
          "notes": "RAD18 TLS"
        }
      ],
      "supporting_genes": [
        "FANCA",
        "FANCB",
        "FANCI",
        "FANCD2",
        "BRCA1",
        "BRCA2",
        "RAD54L",
        "RAD51",
        "RAD51AP1",
        "XRCC2",
        "BRIP1",
        "RAD18",
        "POLQ",
        "DNA2",
        "LIG1"
      ],
      "required_genes_not_in_input": {
        "genes": [
          "FANCG",
          "FANCE"
        ],
        "citations": [
          {
            "url": "https://pmc.ncbi.nlm.nih.gov/75/",
            "source_id": "75",
            "notes": "Full FA pathway components"
          }
        ]
      }
    },
    {
      "program_name": "Chromatin Remodeling & Epigenetic Regulation",
      "description": "ASF1B, CHAF1A/B, UHRF1, HMGB2, HMGN2, HELLS, ESCO2, ATAD2, DNMT1 and associated factors regulate chromatin structure, histone modification, and DNA methylation. Dysregulation modulates DNA accessibility for replication, transcription, and repair, permitting oncogenic programs.",
      "atomic_biological_processes": [
        {
          "name": "Histone chaperone activity",
          "citation": [
            {
              "url": "https://pmc.ncbi.nlm.nih.gov/31/",
              "source_id": "31",
              "notes": "Histone chaperones in cancer"
            }
          ],
          "genes": [
            "ASF1B",
            "CHAF1A",
            "CHAF1B"
          ]
        },
        {
          "name": "DNA methylation maintenance",
          "citation": [
            {
              "url": "https://pmc.ncbi.nlm.nih.gov/34/",
              "source_id": "34",
              "notes": "UHRF1 and DNMT1 axis in cancer"
            }
          ],
          "genes": [
            "UHRF1"
          ]
        }
      ],
      "atomic_cellular_components": [
        {
          "name": "Nucleosome",
          "citation": [
            {
              "url": "https://pmc.ncbi.nlm.nih.gov/30/",
              "source_id": "30",
              "notes": "ASF1 complex in chromatin structure"
            }
          ],
          "genes": [
            "ASF1B",
            "CHAF1A",
            "CHAF1B"
          ]
        }
      ],
      "predicted_cellular_impact": [
        "Permissive chromatin states increase accessibility for replication and transcription",
        "Epigenetic silencing of tumor suppressors facilitates glioblastoma progression",
        "Sensitivity to chromatin structure-targeted therapies"
      ],
      "evidence_summary": "Histone chaperones, UHRF1, and methylation regulators are upregulated in glioblastoma and many other cancers; promote proliferation and progression.",
      "significance_score": 0.78,
      "citations": [
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/31/",
          "source_id": "31",
          "notes": "Chaperones in cancer"
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/34/",
          "source_id": "34",
          "notes": "UHRF1-DNMT1 axis"
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/30/",
          "source_id": "30",
          "notes": "ASF1 complex"
        }
      ],
      "supporting_genes": [
        "ASF1B",
        "CHAF1A",
        "CHAF1B",
        "UHRF1",
        "HMGB2",
        "HMGN2",
        "HELLS",
        "ESCO2",
        "ATAD2"
      ],
      "required_genes_not_in_input": {
        "genes": [
          "DNMT1",
          "EZH2"
        ],
        "citations": [
          {
            "url": "https://pmc.ncbi.nlm.nih.gov/34/",
            "source_id": "34",
            "notes": "Methylation regulators"
          }
        ]
      }
    }
  ],
  "method": {
    "clustering_basis": [
      "GO/KEGG pathway annotations",
      "co-citation networks from PubMed/PMC",
      "protein-protein interaction mapping",
      "co-expression data specific to glioblastoma"
    ],
    "notes": "Gene programs were grouped based on functional interdependence and literature network overlap; clusters emphasize joint presence of most required program components in input list, prioritized by cancer-context overexpression."
  },
  "version": "2025-11-17"
}